rs141166864

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000458.4(HNF1B):​c.1045+12T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,604,964 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00098 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 1 hom. )

Consequence

HNF1B
NM_000458.4 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:6

Conservation

PhyloP100: 1.81

Publications

1 publications found
Variant links:
Genes affected
HNF1B (HGNC:11630): (HNF1 homeobox B) This gene encodes a member of the homeodomain-containing superfamily of transcription factors. The protein binds to DNA as either a homodimer, or a heterodimer with the related protein hepatocyte nuclear factor 1-alpha. The gene has been shown to function in nephron development, and regulates development of the embryonic pancreas. Mutations in this gene result in renal cysts and diabetes syndrome and noninsulin-dependent diabetes mellitus, and expression of this gene is altered in some types of cancer. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
HNF1B Gene-Disease associations (from GenCC):
  • renal cysts and diabetes syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • permanent neonatal diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • transient neonatal diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • medullary sponge kidney
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal dysplasia, bilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal dysplasia, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal hypomagnesemia 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • unilateral multicystic dysplastic kidney
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 17-37731583-A-G is Benign according to our data. Variant chr17-37731583-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 36838.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000978 (149/152280) while in subpopulation AMR AF = 0.00301 (46/15298). AF 95% confidence interval is 0.00232. There are 0 homozygotes in GnomAd4. There are 71 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 149 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNF1BNM_000458.4 linkc.1045+12T>C intron_variant Intron 4 of 8 ENST00000617811.5 NP_000449.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNF1BENST00000617811.5 linkc.1045+12T>C intron_variant Intron 4 of 8 1 NM_000458.4 ENSP00000480291.1

Frequencies

GnomAD3 genomes
AF:
0.000973
AC:
148
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00301
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00110
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00113
AC:
264
AN:
234156
AF XY:
0.00124
show subpopulations
Gnomad AFR exome
AF:
0.000270
Gnomad AMR exome
AF:
0.00187
Gnomad ASJ exome
AF:
0.00227
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000999
Gnomad NFE exome
AF:
0.00146
Gnomad OTH exome
AF:
0.00293
GnomAD4 exome
AF:
0.00114
AC:
1655
AN:
1452684
Hom.:
1
Cov.:
30
AF XY:
0.00116
AC XY:
838
AN XY:
721942
show subpopulations
African (AFR)
AF:
0.0000899
AC:
3
AN:
33376
American (AMR)
AF:
0.00195
AC:
84
AN:
43094
Ashkenazi Jewish (ASJ)
AF:
0.00232
AC:
60
AN:
25908
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39410
South Asian (SAS)
AF:
0.000212
AC:
18
AN:
85098
European-Finnish (FIN)
AF:
0.0000945
AC:
5
AN:
52918
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5762
European-Non Finnish (NFE)
AF:
0.00128
AC:
1416
AN:
1107066
Other (OTH)
AF:
0.00112
AC:
67
AN:
60052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
94
188
281
375
469
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000978
AC:
149
AN:
152280
Hom.:
0
Cov.:
32
AF XY:
0.000954
AC XY:
71
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.000265
AC:
11
AN:
41556
American (AMR)
AF:
0.00301
AC:
46
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00110
AC:
75
AN:
68014
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000931
Hom.:
0
Bravo
AF:
0.00104
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 31, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HNF1B: BS1, BS2

Renal cysts and diabetes syndrome Uncertain:1Benign:1
Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing;curation

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:2
Oct 04, 2016
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Apr 11, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Maturity onset diabetes mellitus in young Uncertain:1
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

HNF1B gene mutations are associated with early onset diabetes and pancreatic atrophy. It is also associated with multiple renal manifestations including renal cysts, Tubulointerstitial disease, glomerulocystic disease, renal hypoplasia, hypomagnesemia. However no sufficient evidence is found to ascertain the role of this particular variant rs141166864, yet.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
8.2
DANN
Benign
0.31
PhyloP100
1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141166864; hg19: chr17-36091574; API